{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02918279","recordId":"NCT02918279","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02918279-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02918279.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02918279.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-09-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-09-27","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"0c880ebd4c98fbaf57c4b3a44e0aa72c5904097dc51d0eeba8022271ea9ce401","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-10-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-06","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"679b6e7d2c3293cabf103f034db4f1e89f402b1ffdfbb0f22c39c8d39d3352ec","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-20","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"7dd127e84aa0c0178f6e28a654a8601306c0a0e3be6f6f1094c7bb8466445ba0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-10-25","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"d90d5bb83b04e4c7a53f188714847b0382091ac21fc61175994baea1596d4b96","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Conditions","Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2016-11-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-11-29","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"9381f3942d0493dd8f2dd01a2109fc25f9ab4c9b90cc09224fe40674cdd9517e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2016-12-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-02","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"900877a53dd0ed21685591dfb8b5333a5b82528d6170fd293b069638570ad16f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2016-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2016-12-15","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"6f463011db1eef0e93dac90a41d8215bce1af5b0ae994834df13a8a0dff442b7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2017-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-06","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"c03cec56022def2f9a0977f51695d2e853683418ef32b17fcfebf0f486798aed","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Description","Study Identification","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2017-01-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-16","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"925b0f47a2d87645b8747310316d71d288f705d5e16270c394588ce7e22b57a3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2017-01-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-01-27","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"fe0867902809dc6181401301fb6f8618f9954b2b69f612b32f1f41d9e3ce362a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2017-02-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-02-03","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"11f9c0e6a82d8212a689786ab56ca2a33342e7b27a15c630acfe3e914f8406c3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2017-02-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-02-14","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"35113017cd35056890dc15077c2d07fb4aff8a0b327e3752b19cf33445899871","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2017-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-03","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"e856d79a93f4ddd5759cbe446b8444018bcf42244c9cb292cdd30a92fb20e05b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2017-03-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-17","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"da64a0d1cf224876307446247cc5a3a762ac3546e388825813f6b14e21512584","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2017-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-03-24","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"6009a0a8e018f379db369bd2a60efb327afdb1f396097313801421006de776b7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2017-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-05","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"13870ccfdc8f44add9bb1b736f4c046d2977aead9a59e30b0988f289afd92c1c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2017-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-04-27","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"cf7a23051c05b2b3968e86fc4dc7bef05a37a93772fef71eacd54fec6180fd3c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2017-05-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-05-19","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"7b928ab8b9a2c67cd298609a94dc03db8c27661dfea5d346d8b15111255deb44","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2017-06-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-06-07","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"a7a92f26056ca9c14ad1159290b2527f92fe7329a223828290fddbd5ae28a840","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2017-08-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-08-18","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"ece59243f35834244549d13d76e56dc368c30a5f59dbde24990e83f61fc7a77b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2017-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-10-25","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"af9397e908fc559e9125c5aa9a184c7997e83cedf71a98f8186dfa60d7918c97","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2017-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2017-11-15","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"6895d9cb98fe1126578e7f4692bdcfe1305d0c58a8da90f7c66e51af85a0a8af","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2018-07-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-07-11","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"c404540bcd66cd91b892747f64e6e53a7216cc24e61aa4e5537e1fa25cf68701","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2018-09-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-09-18","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"06982944e2cdf5fb5f2e4bf2825f8946c099c58b3cdc93b8198d165468bad3ff","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2018-11-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-11-05","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"d7e60bd3fe9234ed6581960fb20af2af791695a08942ea75092b12420d9bbbf8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2018-12-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-12-14","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"b9c84ed8c84a3222634e3fbca119f18fb6eee8260b0658911e95b80324274a61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2019-01-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-01-09","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"4a786c9d38f35ba63597ec7a30f44f5ac77808f8f10c48bca8fd10a2f371a0dd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2019-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-02-12","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"76e5b591725cc0ca67ef9e7c68701b162ad6bf61c1e04883abf6cf9fbb99ad44","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2019-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-03-14","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"280146200b52852466ab6d1ae0e31fdde46a51d5519481d5415deebf1c4ff0fd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=29&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":30,"lastUpdateSubmitQcDate":"2019-04-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-04-04","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"a35b2221a2294f98974491317313162be28193e00a562954024aa46650cd7891","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=30&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":31,"lastUpdateSubmitQcDate":"2019-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-05-09","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"6cd566a77ea0ddfc6bdd7602e91bfcc8645276f9cbbb2a48cfb91d320e9fd771","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=31&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":32,"lastUpdateSubmitQcDate":"2019-06-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-06-19","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"554b41da92d3d9e5e9a9c884ca03bbfcfd427e08a8cb99444146190f6a66577c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=32&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":33,"lastUpdateSubmitQcDate":"2019-07-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-07-05","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"7c1bd351e2be4bb8add4827d26fc6e327a54cb6e8717392df5f044fbb5012b9a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=33&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":34,"lastUpdateSubmitQcDate":"2019-07-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-07-10","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"b280384e4a9bb4a19948e419dc2bcbe8034dfa2ef42e665b733b6a38b14d70ef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=34&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":35,"lastUpdateSubmitQcDate":"2019-07-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-07-23","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"0d38db2c90ff81f688de2465f58d91ec0ed08da3943e1857dd6003916b8e6099","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=35&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":36,"lastUpdateSubmitQcDate":"2019-08-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-08-05","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"a60c977f80c08eec74c1117bb63adf599deada03c56ab8d993d34643a73cc698","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=36&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":37,"lastUpdateSubmitQcDate":"2019-08-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2019-08-12","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"a39e892cdf954b392dcc700bd03dc806dfd45adb0b1cb7d232c20c63519ae32a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=37&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":38,"lastUpdateSubmitQcDate":"2019-08-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2019-08-20","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"4ab2eca89503f90b837fb743e74300ae5141b886df2247c5eb3f1688f5ec21aa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=38&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Status"],"historyVersion":40,"lastUpdateSubmitQcDate":"2020-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2020-04-15","publishedAt":"2026-08-23","recordId":"NCT02918279","recordSha256":"d05ba2c7593b147611ec6c93d5023230d2c8bcdf6c023210b50777065de77e32","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02918279?a=40&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ae7729ed43341a047ffbe593a307f7589676ebd6c56e11565255e3e056fd1b93"}}